Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple complications in multiple organs.
There is neither periosteal apposition nor lesions in soft tissue.
The MRI confirms the presence of several heterogeneous epiphyseal, metaphyseal, and diaphysal lesions presenting hyposignal on T1-weighted images, as well as rounded, well-defined cystic lesions with hypersignal on T2-Fat Sat weighted images (Fig. 2a-c) .Their fluid level is consistent with bleeding lesions. Furthermore, there is peripheric enhancement on T1 post-gadolinium weighted images ( Fig. 2a-c ). There is no intra-articular effusion, and the soft tissue is normal.
These multi-focal lesions in an SLE patient with isolated pancytopenia initially resemble multi-focal bone myelofibrosis.
Renal and autoimmune laboratory tests are normal. Blood smear shows dacryocytes, along with some myelocytes and metamyelocytes. Osteomedullar biopsy shows no presence of malignant cells (blast cells) with a decrease of global cells and an increase of megakaryocytes. Argentic coloration shows an increase of reticulin fibers, consistent with medullar fibrosis. Therefore, the final diagnosis is myelofibrosis.
Discussion
The main cause of myelofibrosis is the imbalance between collagen deposition and collagen destruction by collagenase [1] . In SLE patients, platelet-derived growth factor (PDGF) and transforming growth factor-␤ (TGF-␤) stimulate collagen destruction are increased by autoantibodies Letter fixed on megakaryocytes. SLE patients with myelofibrosis show increased procollagen 1 and 2 in serum, evidence of procollagen synthesis by medullar fibroblasts stimulated by PDGF and TGF-␤. Corticotherapy has an immunosuppressive effect, which classically decreases the number of autoantibodies fixed on megakaryocytes, and thus, decreases fibrosis [2, 3] . In this case, despite corticotherapy long-term treatment, sclerosis is really present in radiographs, representing the only atypical aspect of the myelofibrosis under treatment.
Hematologic disorders affect 85% of SLE patients. However, myelofibrosis is a rare case of SLE pancytopenia [3] [4] [5] [6] . In most cases, chronic inflammatory autoimmune anaemia (70%), thrombopenia by anti-phospholipid syndrome, or hypersplenism is observed [7, 8] .
The diagnosis was confirmed by the pathologist from a bone biopsy.
Conclusion
Myelofibrosis is an uncommon complication of SLE, but the typical radiologic aspect needs to be known to avoid misdiagnosis.
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